InsiderWatch
Try it free

Carl L. Gordon Insider Trades

Director

Director at ADARx Pharmaceuticals, Inc. and 3 other companies. 4 significant open-market trades reported on SEC Form 4 in the last 180 days.

On EDGAR, this filer has 123 Form 4 filings on record since 2004, the latest on Nov 5, 2026. Full history on sec.gov

$61.1M

Bought

$0

Sold

4 / 0

Buys / Sells

4

Companies

Companies

  • ADRXDirector

    ADARx Pharmaceuticals, Inc.

    1 buy, $16.1M · 4 alerts in our log

  • ETRADirector

    Electra Therapeutics, Inc.

    1 buy, $20.0M · 2 alerts in our log

  • BLSMDirector

    BlossomHill Therapeutics, Inc.

    1 buy, $10.0M

  • SCTXDirector

    Scribe Therapeutics, Inc.

    1 buy, $15.0M

Reported Trades

Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.

FiledCompanyTradeValue
Sep 30, 2026ADRXDirectorbuy$16.1M
Sep 23, 2026ETRADirectorbuy$20.0M
Aug 12, 2026BLSMDirectorbuy$10.0M
Jul 29, 2026SCTXDirectorbuy$15.0M

Other Insiders at These Companies

Everyone else who reported a significant open-market trade at the same companies in the last 180 days. Several insiders buying at once is cluster buying.

How to Read This Page

These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR.

Get this insider's next buy when it files

InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.

Try free for 7 days

Every alert we send is logged with its timestamp and source.